ProShare Advisors LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$149,026
-66.4%
17,826
-0.1%
0.00%
-100.0%
Q2 2023$443,319
+88.0%
17,847
+13.8%
0.00%0.0%
Q1 2023$235,767
+16.4%
15,676
-8.5%
0.00%0.0%
Q4 2022$202,636
+132.9%
17,129
+16.6%
0.00%
Q3 2022$87,000
+35.9%
14,686
-1.9%
0.00%
Q2 2022$64,000
-72.3%
14,963
-38.4%
0.00%
Q1 2022$231,000
-57.0%
24,295
-14.1%
0.00%
-100.0%
Q4 2021$537,000
-1.8%
28,297
+72.2%
0.00%
-50.0%
Q3 2021$547,000
-57.6%
16,428
-50.6%
0.00%
-50.0%
Q2 2021$1,290,000
-17.8%
33,256
+2.2%
0.00%
-20.0%
Q1 2021$1,569,000
+18.1%
32,545
+27.4%
0.01%0.0%
Q4 2020$1,328,000
+264.8%
25,538
+87.6%
0.01%
+150.0%
Q3 2020$364,000
+42.2%
13,613
+3.7%
0.00%
+100.0%
Q2 2020$256,000
+96.9%
13,128
+12.4%
0.00%0.0%
Q4 2019$130,000
+21.5%
11,682
+2.1%
0.00%0.0%
Q2 2014$107,000
-1.8%
11,442
-27.3%
0.00%0.0%
Q1 2014$109,00015,7380.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders